GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Durect Corp (FRA:DC8A) » Definitions » Accounts Payable & Accrued Expense for Financial Companies

Durect (FRA:DC8A) Accounts Payable & Accrued Expense for Financial Companies


View and export this data going back to . Start your Free Trial

What is Durect Accounts Payable & Accrued Expense for Financial Companies?

Accounts Payable & Accrued Expense for Financial Companies only applies to insurance companies.


Durect (FRA:DC8A) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Durect Corp (FRA:DC8A) » Definitions » Accounts Payable & Accrued Expense for Financial Companies
Traded in Other Exchanges
Address
10260 Bubb Road, Cupertino, CA, USA, 95014
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .